Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

NCT04336241 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

BIOLOGICAL: RP2
BIOLOGICAL: nivolumab

Sponsor

Replimune, Inc.